Tiffany Runyan Garrison

Author

Abbott Fund

Also Known As

T R Garrison, Tiffany Garrison, Tiffany R. Garrison, Tiffany Runyan Garrison

Publications

Citations

H-Index

Concepts

All Affiliations

Abbott Fund Duke University Hospital Howard Hughes Medical Institute Yale University Duke Medical Center

About

Tiffany Runyan Garrison is an author at Abbott Fund specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	651
2	Health Sciences	4	4	180
3	Natural Sciences	4	4	374
4	Biochemistry	4	4	326
5	Social Sciences	1	1	15

Tiffany Runyan Garrison

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα D. Scott Witherow, Tiffany Runyan Garrison, William E. Miller, Proceedings of the National Academy of Sciences	2004	249
Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference Seungkirl Ahn, Christopher Nelson, Tiffany Runyan Garrison, Proceedings of the National Academy of Sciences	2003	235
Reciprocal Regulation of Angiotensin Receptor-activated Extracellular Signal-regulated Kinases by β-Arrestins 1 and 2 Seungkirl Ahn, Huijun Wei, Tiffany Runyan Garrison, Journal of Biological Chemistry Reciprocal ActivityCellular PhysiologyMolecular PharmacologySignaling PathwayReceptor Tyrosine Kinase	2004	173
Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB<sub>2</sub> Cannabinoid Receptor Activity Jennifer M. Frost, Michael J. Dart, Karin Tietje, Journal of Medicinal Chemistry Cannabis UseMolecular PharmacologyMedicinal ChemistryIndol-3-ylcycloalkyl KetonesBiochemistry	2009	139
<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB<sub>2</sub>receptor agonist exhibiting analgesic activity in rodent pain models B. B. Yao, Gin C. Hsieh, Jennifer M. Frost, British Journal of Pharmacology	2007	136
and Alzheimer's disease Jorge D. Brioni, Tim Esbenshade, Tiffany Runyan Garrison, Neurodegenerative DiseasesAlzheimer's DiseaseDementiaNeurologyNeuroscience	2010	125
Selective Uncoupling of RGS Action by a Single Point Mutation in the G Protein α-Subunit Paul R. DiBello, Tiffany Runyan Garrison, Donald Apanovitch, Journal of Biological Chemistry	1998	117
<i>In vitro</i>pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB<sub>2</sub>receptor? B. B. Yao, Sromona Mukherjee, Yaotian Fan, British Journal of Pharmacology	2006	112
Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging Betty Yao, Gin C. Hsieh, A.V. Daza, Journal of Pharmacology and Experimental Therapeutics	2008	91
Analysis of RGS Proteins in Saccharomyces cerevisiae Ginger A. Hoffman, Tiffany Runyan Garrison, Henrik Dohlman Methods in enzymology on CD-ROM/Methods in enzymology Rgs ProteinsBiochemistryNatural SciencesMolecular BiologyYeast	2002	91

Page 1